During the past decade, Kaiser Permanente Oncology/Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Oncology/Hematology" #1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Oncology/Hematology" are "Prostate Cancer" (2 trials), "Colonic Neoplasms" (1 trials), "Colorectal Neoplasms" (1 trials), "Multiple Myeloma" (1 trials) and "Non-small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Kaiser Permanente Oncology/Hematology" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Oncology/Hematology" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Bevacizumab placebo (ie saline solution)" (1 trials), "Bortezomib" (1 trials), "CT-322" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Oncology/Hematology" are 3 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Oncology/Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kaiser Permanente Oncology/Hematology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Oncology/Hematology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".